Potential Genetic Marker of Colorectal Cancer Risk Found

This article originally appeared here.
Share this content:
Potential Genetic Marker of Colorectal Cancer Risk Found
Potential Genetic Marker of Colorectal Cancer Risk Found

(HealthDay News) – There is an association between an increase in the degree of germline allele-specific expression (ASE) of the adenomatous polyposis coli (APC) gene and the risk of common forms of colorectal cancer (CRC), according to a study published in the January issue of Gastroenterology.

Maria Cristina Curia, MD, of "G. d'Annunzio" University in Chieti, Italy, and colleagues investigated the role of germline variations in ASE in CRC. To do this, blood samples from 53 CRC cases and 68 controls were analyzed using high-performance liquid chromatography for the degree of variation in ASE in the APC gene. Screening for sequence variants and single-nucleotide polymorphism genotyping was also performed.

Compared with controls, the researchers found patients with CRC to be at a 3.97-fold increased risk of CRC if their ASE deviated more than one standard deviation from the mean, and they were at a 13.46-fold increased risk of CRC if their ASE deviated more than 1.645 standard deviations from the mean. A nonsense mutation in APC (p.Arg216X) was found in a patient without a family history of CRC but who had a high level of ASE.

"CRC risk appeared to increase proportionally with the degree of APC ASE, providing evidence that imbalanced ASE of APC is a novel promising indicator of CRC predisposition. These data support the conclusion that the same genes that predispose to rare, highly penetrant, familial cancer may act in apparently sporadic cancer by mechanisms causing ASE," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs